Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of intravenous bortezomib in patients with chronic hepatitis C
2008-000495-24Phase 2Completed
- Sponsor
- ViroLogik
- Start
- Feb 2008
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bortezomib in chronic hepatitis C (CHC), sponsored by ViroLogik. Primary endpoint: Change in hepatitis C viral load. Started Feb 2008; status: completed.
02
Drugs
bortezomib
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on 2008-000495-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000495-24.